Vanguard Group’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,005
| Closed | -$23.6K | – | 4287 |
|
|
2024
Q4 | $23.6K | Sell |
1,005
-813
| -45% | -$25.4K | ﹤0.01% | 4251 |
|
|
2024
Q3 | $60.9K | Sell |
1,818
-735
| -29% | -$29.1K | ﹤0.01% | 4234 |
|
|
2024
Q2 | $130K | Sell |
2,553
-594
| -19% | -$43.8K | ﹤0.01% | 4205 |
|
|
2024
Q1 | $392K | Sell |
3,147
-60
| -2% | -$6.9K | ﹤0.01% | 4069 |
|
|
2023
Q4 | $520K | Sell |
3,207
-103
| -3% | -$19.5K | ﹤0.01% | 4024 |
|
|
2023
Q3 | $826K | Hold |
3,310
| – | – | ﹤0.01% | 3902 |
|
|
2023
Q2 | $1.74M | Hold |
3,310
| – | – | ﹤0.01% | 3709 |
|
|
2023
Q1 | $2.57M | Hold |
3,310
| – | – | ﹤0.01% | 3585 |
|
|
2022
Q4 | $994K | Buy |
3,310
+1
| +0% | +$423 | ﹤0.01% | 3918 |
|
|
2022
Q3 | $1.67M | Hold |
3,309
| – | – | ﹤0.01% | 3818 |
|
|
2022
Q2 | $1.89M | Hold |
3,309
| – | – | ﹤0.01% | 3829 |
|
|
2022
Q1 | $4.27M | Sell |
3,309
-17
| -0.5% | -$18.8K | ﹤0.01% | 3610 |
|
|
2021
Q4 | $3.79M | Sell |
3,326
-5
| -0.2% | -$6.85K | ﹤0.01% | 3768 |
|
|
2021
Q3 | $5.1M | Hold |
3,331
| – | – | ﹤0.01% | 3648 |
|
|
2021
Q2 | $6.59M | Hold |
3,331
| – | – | ﹤0.01% | 3432 |
|
|
2021
Q1 | $6.13M | Buy |
3,331
+1,602
| +93% | +$3.51M | ﹤0.01% | 3420 |
|
|
2020
Q4 | $3.79M | Buy |
+1,729
| New | +$4.48M | ﹤0.01% | 3481 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$23K | – | 4175 |
|
|
2019
Q1 | $23K | Hold |
1
| – | – | ﹤0.01% | 4097 |
|
|
2018
Q4 | $29K | Sell |
1
-4
| -80% | -$137K | ﹤0.01% | 4104 |
|
|
2018
Q3 | $183K | Hold |
5
| – | – | ﹤0.01% | 4010 |
|
|
2018
Q2 | $416K | Hold |
5
| – | – | ﹤0.01% | 3853 |
|
|
2018
Q1 | $596K | Hold |
5
| – | – | ﹤0.01% | 3751 |
|
|
2017
Q4 | $933K | Buy |
5
+1
| +25% | +$284K | ﹤0.01% | 3627 |
|
|
2017
Q3 | $1.29M | Hold |
4
| – | – | ﹤0.01% | 3523 |
|
|
2017
Q2 | $1.4M | Hold |
4
| – | – | ﹤0.01% | 3493 |
|
|
2017
Q1 | $3.63M | Buy |
4
+1
| +33% | +$834K | ﹤0.01% | 3176 |
|
|
2016
Q4 | $2.23M | Buy |
3
+1
| +50% | +$1.01M | ﹤0.01% | 3327 |
|
|
2016
Q3 | $989K | Hold |
2
| – | – | ﹤0.01% | 3574 |
|
|
2016
Q2 | $952K | Hold |
2
| – | – | ﹤0.01% | 3614 |
|
|
2016
Q1 | $1.02M | Buy |
2
+1
| +100% | +$617K | ﹤0.01% | 3596 |
|
|
2015
Q4 | $1.15M | Hold |
1
| – | – | ﹤0.01% | 3575 |
|
|
2015
Q3 | $1.12M | Hold |
1
| – | – | ﹤0.01% | 3598 |
|
|
2015
Q2 | $1.63M | Buy |
+1
| New | +$2.03M | ﹤0.01% | 3498 |
|
Other funds holding HEPA
SM
AFM
HF
TRCT
SS
